Quest Diagnostics Incorporated (DGX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 136.14 |
| Open | 136.12 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1100 |
| Day's Range | 136.00 - 138.37 |
| 52 Week Range | 119.59 - 145.58 |
| Volume | |
| Avg. Volume | 983,198 |
| Market Cap | 15.348B |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | 18.59 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.00 (2.17%) |
| Ex-Dividend Date | Apr 05, 2024 |
| 1y Target Est | N/A |
- Zacks
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
- Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
- Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
© 2024 Yahoo. All rights reserved.